Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy

Androgen Deprivation ◽

Intermediate Risk ◽

Image Guided Radiotherapy ◽

Image Guided ◽

Risk Prostate Cancer ◽

Hypofractionated Radiation

Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients

Brachytherapy ◽

10.1016/j.brachy.2013.05.004 ◽

2014 ◽

Vol 13 (1) ◽

pp. 59-67 ◽

Cited By ~ 14

Author(s):

Ovidiu Marina ◽

Gary S. Gustafson ◽

Larry L. Kestin ◽

Donald S. Brabbins ◽

Peter Y. Chen ◽

...

Keyword(s):

Prostate Cancer ◽

Dose Rate ◽

Cancer Patients ◽

High Dose Rate ◽

High Dose ◽

Intermediate Risk ◽

Image Guided Radiotherapy ◽

Image Guided ◽

Risk Prostate Cancer ◽

Brachytherapy Boost

Short-term-androgen-deprivation therapy reduces disease recurrence in intermediate-risk-prostate-cancer patients receiving high-dose radiotherapy?

Reports of Practical Oncology & Radiotherapy ◽

10.1016/j.rpor.2013.03.520 ◽

2013 ◽

Vol 18 ◽

pp. S334

Author(s):

M. Cabeza Rodriguez ◽

J. Olivera ◽

P. Samper Ots ◽

A. Cascales Garcia ◽

C. Diaz ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Disease Recurrence ◽

Androgen Deprivation ◽

High Dose ◽

Intermediate Risk ◽

Short Term ◽

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1120 ◽

2017 ◽

Vol 99 (2) ◽

pp. E216 ◽

Cited By ~ 1

Author(s):

P. Bonome ◽

M.F. Osti ◽

M. Giuliani ◽

V. De Sanctis ◽

D. Caivano ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Intermediate Risk ◽

Image Guided ◽

Risk Prostate Cancer ◽

Hypofractionated Radiation Therapy ◽

Hypofractionated Radiation

Is Androgen Deprivation Therapy Necessary in Intermediate Risk Prostate Cancer Patients Treated in the Dose Escalation Era?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.083 ◽

2011 ◽

Vol 81 (2) ◽

pp. S40-S41

Author(s):

K.O. Castle ◽

K.E. Hoffman ◽

L.B. Levy ◽

A.K. Lee ◽

S. Choi ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Dose Escalation ◽

Androgen Deprivation ◽

Intermediate Risk ◽

Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.06.030 ◽

2013 ◽

Vol 85 (3) ◽

pp. 693-699 ◽

Cited By ~ 39

Author(s):

Katherine O. Castle ◽

Karen E. Hoffman ◽

Lawrence B. Levy ◽

Andrew K. Lee ◽

Seungtaek Choi ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Dose Escalation ◽

Androgen Deprivation ◽

Intermediate Risk ◽

Does Androgen Deprivation Therapy Improve Ten-Year Clinical Outcomes of Intermediate Risk Prostate Cancer Patients Treated with Brachytherapy with or without External Beam Radiotherapy?

Brachytherapy ◽

10.1016/j.brachy.2019.04.130 ◽

2019 ◽

Vol 18 (3) ◽

pp. S61-S62

Author(s):

Atsunori Yorozu ◽

Shinya Sutani ◽

Takashi Soyano ◽

Yutaka Shiraishi ◽

Kazuhito Toya ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

External Beam Radiotherapy ◽

Androgen Deprivation ◽

External Beam ◽

Intermediate Risk ◽

Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy

Radiation Oncology ◽

10.1186/s13014-016-0656-0 ◽

2016 ◽

Vol 11 (1) ◽

Cited By ~ 1

Author(s):

Stefano Bracci ◽

Mattia F. Osti ◽

Linda Agolli ◽

Luca Bertaccini ◽

Vitaliana De Sanctis ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Androgen Deprivation ◽

Hypofractionated Radiotherapy ◽

Intermediate Risk ◽

Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2019.100119 ◽

2019 ◽

Vol 19 ◽

pp. 100119

Author(s):

Carlos E. Vargas ◽

Now Bahar Alam ◽

Mitchell Terk ◽

Joshua R. Niska ◽

Jamie Cesaretti ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation ◽

Phase Iii ◽

High Dose ◽

Intermediate Risk ◽

Phase Iii Trial ◽

Image Guided ◽

Risk Prostate Cancer ◽

Initial Results

806 Serum testosterone during neoadjuvant androgen deprivation therapy is a significant predictor of the prognosis in high and intermediate risk prostate cancer patients under radiation therapy

European Urology Supplements ◽

10.1016/s1569-9056(15)60795-3 ◽

2015 ◽

Vol 14 (2) ◽

pp. e806-e806a

Author(s):

K. Wakai ◽

S. Sakamoto ◽

K. Andou ◽

A. Muroi ◽

K. Shuhei ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Intermediate Risk ◽

Whole-Pelvic Versus Prostate-Only Radiation Therapy in Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Brachytherapy Boost

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.293 ◽

2018 ◽

Vol 102 (3) ◽

pp. e150-e151

Author(s):

D.D. Yang ◽

B.A. Mahal ◽

V. Muralidhar ◽

N.E. Martin ◽

M. King ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Androgen Deprivation ◽

Intermediate Risk ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Brachytherapy Boost